News | Structural Heart Occluders | August 08, 2016

AAN: PFO Closure Not Recommended for People with Heart Defect and Stroke

Updated American Academy of Neurology recommendation cites limited evidence, availability of PFO closure devices as method to prevent second stroke

PFO closure, patent foramen ovale, AAN recommendation, American Academy of Neurology, stroke patients

August 8, 2016 — Updated recommendations from the American Academy of Neurology (AAN) states that catheter-based closure should not be routinely recommended for people who have had a stroke and also have a heart defect called a patent foramen ovale (PFO), a channel between the top two chambers in the heart. The practice advisory, which updates a previous AAN guideline, was published in the July 27, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology.

To develop the advisory, researchers reviewed all available scientific studies on people with PFO who also had an ischemic stroke, which is a stroke caused by a blood clot, or a transient ischemic attack, which is an episode of temporary stroke symptoms.

“Compared with other ways to prevent a second stroke, such as medications to reduce blood clots, the devices used to close a patent foramen ovale have limited evidence to support their use,” said practice advisory author Steven R. Messé, M.D., with the Perelman School of Medicine at the University of Pennsylvania in Philadelphia and a Fellow of the American Academy of Neurology. “It’s still uncertain how effective these devices are in reducing stroke risk, and the procedure is associated with uncommon but potentially serious complications.”

Read article on how transcatheter structural heart repair is becoming mainstream in the cath lab.

In addition, Messé noted that the devices used for PFO closure are not available for routine use in the United States, so the procedure must be done off-label with a device approved for treating a similar heart defect or with another device that does not have strong evidence regarding its use. At the time of publication, the U.S. Food and Drug Administration is currently reviewing the one device that has the best evidence regarding closure.

Read article on FDA panel's recommendation of the St. Jude Amplatzer PFO Occluder System to prevent recurrent ischemic stroke in certain patients.

“People should know that having a PFO is common — one in four people have one — and the risk of having a second stroke is low,” Messé said.

When the AAN developed the earlier guideline on this topic in 2004, not enough evidence was available to make a recommendation on whether closing a PFO was effective in reducing stroke risk.

The advisory also recommends that aspirin or other antiplatelet drugs be used to prevent blood clots instead of anticoagulant drugs such as warfarin and heparin, also known as blood thinners, unless there is another reason to use blood thinners, such as a person with a history of blood clots in the legs or lungs.

The practice advisory was supported by the American Academy of Neurology.

For more information: www.neurology.org

Related Content

Renal Cysts May Signal Stroke Risk
News | Stroke | February 05, 2018
February 5, 2018 — Sacs of fluid in the kidneys may indicate there is also blood vessel damage in the brain and a ...
Study Shows Embotrap Device Usage During Stroke Treatment Yields Positive Rates Revascularization
News | Stroke | February 01, 2018
February 1, 2018 – EmboTrap Device, a...
Results of the PROMISE Study Presented at International Stroke Conference
News | Stroke | January 25, 2018
January 25, 2018 – Penumbra Inc. today announced results of the company-sponsored PROMISE...
Majority of High-Risk Stroke Patients Not Being Screened for Common Risk Factors
News | Stroke | September 28, 2017
September 28, 2017 — New research revealed that on average, more than 75 percent of people aged 65 and older worldwid
SanBio Receives $20 Million Grant for Stroke Clinical Trial
News | Stroke | July 12, 2017
July 12, 2017 — SanBio Inc.
German Workshop Highlights Possibilities of Perfusion MRI
News | Stroke | July 03, 2017
When diagnosing strokes and heart diseases or looking at tumors, perfusion magnetic resonance imaging (MRI) offers a...
Stroke History Higher in Asymptomatic Versus Symptomatic Atrial Fibrillation Patients
News | Stroke | June 28, 2017
Newly diagnosed asymptomatic atrial fibrillation patients have a higher rate of previous stroke than those with...
Analysis Shows Increased Risk of Early Stroke with New-Onset Atrial Fibrillation Post-TAVR, SCAI 2017 late-breaking clinical trial
News | Stroke | May 12, 2017
More than one-third of patients undergoing transcatheter aortic valve replacement (TAVR) were observed to have atrial...
hyperbaric oxygen treatment, HBOT, stroke, David Steenblock D.O.

Image courtesy of David Steenblock, D.O.

News | Stroke | April 06, 2017
David Steenblock, D.O., an osteopathic physician based in San Clemente, Calif., recently discussed his use of...
marijuana use, increased risk, stroke, heart failure, ACC 2017 study
News | Stroke | March 15, 2017
Using marijuana raises the risk of stroke and heart failure even after accounting for demographic factors, other health...
Overlay Init